Puma Biotechnology Inc (NYSE:PBYI)

Data as of Sep 12
 -2.85 / -1.04%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Puma Biotechnology, Inc. is a development stage biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. The company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seek to further develop those drug candidates for commercial use. Puma Biotechnology was founded by Alan H. Auerbach on September 15, 2010. Its predecessor company, Innovative Acquisitions Corp was originally incorporated in Delaware in April 2007 as a shell company and later acquired and merged itself into Puma Biotechnology, Inc. in October 2011. The company is headquartered in Los Angeles, CA.

Contact Information

Puma Biotechnology, Inc.
10880 Wilshire Boulevard
Los Angeles California 90024
P:(424) 248-6500
Investor Relations:



Mutual fund holders48.81%
Other institutional35.10%
Individual stakeholders32.82%

Top Executives

Alan H. AuerbachChairman, President & Chief Executive Officer
Charles R. EylerTreasurer & Senior Vice President-Administration
Richard Paul BryceSenior VP-Clinical Research & Development
Cheryl CollettController
Mariann OhanesianSenior Director-Investor Relations

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.